Tigermed Executes Share Buyback, Spending RMB 1.838 Million on June 25

Stock News06-25

Hangzhou Tigermed Consulting Co.,Ltd. (ASX: 300347) has announced a share repurchase transaction.

The company disclosed that on June 25, 2026, it utilized RMB 1.838 million to buy back 43,100 of its A-shares.

The repurchase price per share ranged between RMB 42.44 and RMB 42.78.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment